微信扫码登录
自选
APP下载
扫一扫,下载

1Q25 CoR outperformed

原文出处: 招银国际   贡献者:研报专业户
中国财险(02328)\r

PICC P&C reported a strong1Q25earnings alert,with net profit expected to surge80%-100%YoY to RMB10.6bn-11.7bn,implying a QoQ upswing of95.3%-117%vs4Q24(link).1Q25net profit represented more than one-third(33%-37%)of lastyear’s total net profit,driven by1)a largely improved CoR with reduced catastrophicclaims in1Q25;and2)optimized asset allocation structure shifting from the FVTPLto FVOCI,which helped smooth the volatilities from fair value movement to achievesteady investment income growth amid market fluctuations.We estimate the1Q25CoR to arrive at less than95%,and adjust the auto/non-auto CoR to95.9%/99.0%(prev.96.0%/98.9%report)in FY25E,thanks to stringent expensecontrols and an improved non-auto UW structure.For auto,we expect thepremium growth to be driven by the rise of new vehicle sales and a higherpenetration of NEVs;and for non-auto,we pare down FY25E premium growthforecast to6%as the insurer could prioritize profitability to UW expansion,in ourview.On investment,we expect the insurer to steadily increase equity allocation tohigh-yield stocks under FVOCI,on top of the40%growth in FY24,and1Qinvestment income could be bolstered by equity gains and a rebounded bond yield.Maintain BUY,with TP at HK$15.8(unchanged),implying1.19x FY25E P/BV.\r

1Q25CoR improved on narrowed claims.According to the data from MEM*,total direct economic losses from NAT CAT claims amounted to RMB9.3bn in1-2M25(vs1-2M24:RMB20.7bn),down55%YoY,evidenced for a reduced totalamount of P&C claims across the sector.We expect the insurer’s1Q25CoR toland at less than95%,down approx.3pct YoY on top of a high base of97.9%in1Q24,which was dragged by deteriorated catastrophe-induced claims fromfreezing rains.In1Q25,we expect non-auto CoR to trim faster than auto CoR,as the insurer re-addresses on non-auto expense controls and determines toscale down the loss-making lines suchlike the employer’s liability insurance andcredit insurance.Auto CoR could slightly improve with avg.ticket size stabilizedacross peers.We adjust the auto/non-auto CoR forecasts to95.9%/99.0%(prev.96.0%/98.9%)in FY25E,to reflect an improved auto structure tilted tohousehold vehicles,which made up74.3%of FY24auto premiums;and the riskmitigation in non-auto potentially taking more time.\r

Expect1Q25H-share surge to drive investment gains.The insurer hasreallocated investment fund portfolio to FVOCI assets.In FY24,FVTPL/FVOCIassets were down16.6%/up35.3%YoY to make up18%/36%of total portfolio.On equities,stocks in FVOCI/FVTPL increased40%/20%YoY whilst equityfunds were stable to a rise of0.3%YoY,comprising5.8%/1.4%/2.2%of totalinvestment assets by end-FY24.In1Q25,the HSI/HSCEI jumped15%/17%(vs1Q24:-3%/+1%,Fig1),which could enhance the insurer’s equity gains.Beyond that,China’s10YR govt.bond yield rose14.4bps to1.82%in1Q25(vs1Q24:-28bps),driving the growth of bond interests.Looking ahead,weexpect the insurer to steadily edge up allocation to FVOCI stocks and LT govt.bonds to smooth the fair value movement for a stable LT investment income.\r

Valuation and risks.The stock is trading at1.06x FY25E P/B with3yr-forwardROE at13.6%.Considering investment movements,we adjust FY25-27E EPSforecasts by3%/1%/-1%to RMB1.62/1.76/1.91,and remain positive on theinsurer’s UW results to meet the full-year guidance of1)auto/NEV CoR lessthan96%/100%,and2)non-auto CoR less than99%.Maintain BUY,with TPunchanged at HK$15.80based on P/B-ROE,implying1.19x FY25E P/BV.Keyrisks involve deteriorated CoR,and intense equity market volatilities,etc.\r

Source:Company data,Bloomberg,CMBIGM estimates\r

MORE REPORTS FROM BLOOMBERG:RESP CMBROR http://www.cmbi.com.hk\r

Note:the MEM stands for the Ministry of Emergency Management.\r

Key forecasts\r

Current Old Change(pct)\r

Source:Company data,CMBIGM estimates\r

Investment asset portfolio by asset type and YoY%,FY24/FY23Investment assets Mix%
13.72 -0.58% -0.08

TA关联分析

  • 买入
    操作
  • --
    趋势
  • 15.8
    估值
  • --
    基本面
你建议本股当前如何操作?
  • 买入
  • 观望
  • 卖出
表情
同时转发
  • 东吴证券 04/16
    操作:买入
    买入价: 14.06
    我们看好公司作为财险行业龙头的长期盈利优势,维持此前盈利预测不变,预计2025-2027年公司归母净利润为352/379/419亿元,当前市值对应2025E PB0.9x。维持“买入”评级。2025Q1业绩预增:承保与投资业绩均提升,净利润接近翻倍
  • 申万宏源 03/31
    操作:买入
    买入价: 14.40
    我们预计25-27年公司净利润分别达349.54/389.89/442.89亿元(此前25-26年预期为348.41/380.28亿元)。作为保险板块内高股息核心标的,在当前市场风格下估值依然具有安全垫;公司持续推进高质量转型,经营优势有望持续显现。截至3月28日,公司PB(25E)为1.06x,维持“买入”评级。投资驱动利润稳增,大灾阶段性影响COR表现
  • 光大证券 03/29
    操作:买入
    买入价: 14.40
    公司作为财险行业龙头,加快推进“保险+风险减量服务+科技”新商业模式,加强各领域科技赋能,持续优化保险产品供给,全面实施风险减量服务工程,强化高风险业务管控,并通过“价费联动”提升其精算定价能力及精细化管理水平,夯实稳健发展基础,综合实力强劲,2024年公司在财险行业市场份额达31.8%,稳居行业首位。预计未来随着公司进一步优化业务经营模式,持续深入推进提质降本增效以及大灾影响减弱,25年COR有望同比改善,进而释放利润。结合24年业绩表现,我们调整公司2025-2026归母净利润分别至374/433亿元(前值为369/413亿元),新增2027年预测504亿元。目前股价对应公司2025-2027年PB分别为1.04/0.94/0.84,仍处于历史较低水平,维持“买入”评级。2024年年报点评:车险承保稳健,投资推升业绩

请点击右上角的【...】按钮

选择【浏览器】打开

×